Ji Vl ek (Absent Minded) Prof. of Clinical pharmacy and - PowerPoint PPT Presentation

Ji ř í Vl č ek (Absent Minded) Prof. of Clinical pharmacy and Pharmaceutical care Charles University in Prague Clinical pharmacist in University hospital Hradec Králové Czech Republic Chairman of LOC 15 th ISoP Meeting vlcek@faf.cuni.cz

¡ Spring 2013: To invite or not to invite ISoP to the Czech Republic? Algorithm SAFE – complete risk minimization activity § Population risk S ignal of risk no….stop/yes ê it is a lot of work to organize a meeting, inter-professional factor § Individual risk A nalysis of risk no…..stop/yes ê lack of PhD programs in the PV field, we don´t know majority of people from ISoP § Judgement of individual risk F ounding of ways of risk measurement no…stop/yes ê BENEFIT: Delegates experienced in the PV field coming to Prague, bringing profit to students § How to manage risk E limination of risk § Strong LOC, support from the University, regulator and industry partners. Hervé´s visit in January 2014 in Prague, proactive PCO: C-IN

Roles of different professions participating in risk management in algorithm SAFE Risk signal individual founding elimination rate § Physician ++ ++++ ++++ +++ 13 § Clinical pharmacist ++++ +++ +++ ++++ 14 § Nurse ++ ++ + ++ 7 § Community pharmacist ++ ++ + ++ 7 § Patient + + + + 4

The original idea… § Patient safety § Scientific method in Pharmacovigilance - PhD projects § Risk management on individual and population level § Individual alert making harm and how they are recognized § Future in PV § Education in PV

In order to live up to expectations of the “Cubism in pharmacovigilance“ topic of our Meeting, we tried to cover the following fields… 1/ Risk management 2/ Herbal safety 3/ PRAC in Prague 4/ Big data 5/ Patient perspective of drug safety 6/ Medication errors 7/ Role of communication in patient safety 8/ Women health

Cubism vs. Pharmacovigilance Both cubism in early 20 th century and PV in early 21 st century bring something new. Pharmacovigilance brings: • Patient should be included into the risk management • Team work in PV is important and ISoP seems to be a good base • Social media can be use for PV purposes • Different tools for risk management • Pharmacological knowledge is an important part of PV and we need to learn how to use it • Invite PRAC members and don´t let them fly out without discussion • Medication adherence management is a challenge in risk management • Medication errors are important part of risk • We have to educate teachers and health care workers about recent PV and its role in patient safety

ISoP in figures 384 Delegates registered 60 Countries represented 378 Total room nights in the Clarion hotel 179 Posters 31 Invited lectures 29 Oral presentations

Delegates overview Country # Delegates Delegates per country Czech Republic 59 France 36 70 ¡ United Kingdom 31 USA 25 60 ¡ Germany 18 50 ¡ Sweden 12 Italy 11 40 ¡ Netherlands 11 Switzerland 11 30 ¡ Argentina 9 Portugal 9 20 ¡ South Korea 8 Mexico 8 10 ¡ Belgium 7 Slovak Republic 7 0 ¡ Canada 6 Ghana 6 India 6 Turkey 6 Brazil 5 Morocco 5

Scientific Committee § Gunilla Sjölin-Forsberg (Sweden) § Emily Banks (Australia) § Veronique Kugener (USA) § Yola Moride (Canada) § Rachida Soulaymani (Morocco) § Souad Skalli (Morocco) § Marco Tuccori (Italy) § Everardo Vazquez (Mexico) § Ian C.K. Wong (China - Hong Kong)

Local Organising Committee § Medical part § Jan Petrá č ek MD, Radek B ě la MD, Assoc. Prof. Martin Votava MD § Pharmaceutical part § Mgr Tatiana Belkina, Mgr. Veronika De š č íková, PharmDr. Petra Matoulková, PhD § PharmDr. Krist ý na Schneiderová, Mgr. Irena Storová, PharmDr. Lucie Š edová

My students and colleagues – volunteers (blue T-shirt group) § PharmDr. Jan Kost ř iba, PhD § PharmDr. Eva Zim č íková, PhD § PharmDr. Jitka Pokladníková, PhD § Mgr. Karel Hloch § Mgr. Jan Vosátka § Mgr. Julie Strá ž nická § Mgr. Ricarda Meincke

C- IN - Professional Congress Organiser ¡ § Karel Je ž ek § Andrea Mare š ová and their team

Our gratitude goes to… • Chairmen of all sessions • ISoP Executive Committee • All participants creating the scientific community

Thank you for your contribution and have a safe trip back home!